These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1472103)

  • 1. Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells.
    Nègre-Salvayre A; Fitoussi G; Troly M; Salvayre R
    Biochem Pharmacol; 1992 Dec; 44(12):2379-86. PubMed ID: 1472103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
    Sevanian A; Shen L; Ursini F
    Pharm Res; 2000 Aug; 17(8):999-1006. PubMed ID: 11028948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide.
    Mak IT; Zhang J; Weglicki WB
    Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N; Triggle DJ
    Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol.
    Duncker DJ; Saxena PR; Verdouw PD
    Eur J Pharmacol; 1988 Nov; 156(3):401-9. PubMed ID: 3215283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different potencies of dihydropyridine derivatives in blocking T-type but not L-type Ca2+ channels in neuroblastoma-glioma hybrid cells.
    Stengel W; Jainz M; Andreas K
    Eur J Pharmacol; 1998 Jan; 342(2-3):339-45. PubMed ID: 9548406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
    Sugawara H; Tobise K; Kikuchi K
    Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium release from pituitary secretory granules: modulation by thiols, disulfides, and dihydropyridine calcium channel blockers.
    Lorenson MY; Cuccaro ML; Jacobs LS
    Endocrinology; 1990 May; 126(5):2671-8. PubMed ID: 1691704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant effects of 1,4-dihydropyridine and nitroso aryl derivatives on the Fe+3/ascorbate-stimulated lipid peroxidation in rat brain slices.
    Díaz-Araya G; Godoy L; Naranjo L; Squella JA; Letelier ME; Núñez-Vergara LJ
    Gen Pharmacol; 1998 Sep; 31(3):385-91. PubMed ID: 9703206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of calcium-channel blockers on cell proliferation, DNA and collagen syntheses, and EGF receptors of cultured gingival fibroblasts derived from human nifedipine, nicardipine and nisoldipine responders.
    Matsumoto H; Noji I; Akimoto Y; Fujii A
    J Oral Sci; 2001 Dec; 43(4):261-8. PubMed ID: 11848193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells.
    Nègre-Salvayre A; Pieraggi MT; Mabile L; Salvayre R
    Atherosclerosis; 1993 Mar; 99(2):207-17. PubMed ID: 8503949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines.
    Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK
    Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
    Matsushima S; Tanaka T; Saitoh M; Watanabe M; Hidaka H
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1468-74. PubMed ID: 2825687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.
    Napoli C; Chiariello M; Palumbo G; Ambrosio G
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):417-24. PubMed ID: 8924055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways.
    Negre-Salvayre A; Alomar Y; Troly M; Salvayre R
    Biochim Biophys Acta; 1991 Jun; 1096(4):291-300. PubMed ID: 2065102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes.
    Li Q; Tallant A; Cathcart MK
    J Clin Invest; 1993 Apr; 91(4):1499-506. PubMed ID: 8473496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
    Thayer SA; Welcome M; Chhabra A; Fairhurst AS
    Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.